BAXTER INTERNATIONAL INC (BAX) Stock Price, Financials & Summary

Price chart

Sep 17Sep 22Sep 25Sep 30Oct 5Oct 8Oct 13Oct 16

Key dataOct 16, 2026

Open$25.95

From 52W high−10.78%

Volume2.48M

Market cap$13.08B

P/E (TTM)—

P/S (TTM)1.1x

Div yield0.16%

Key dataOct 16, 2026

Open

$25.95

From 52W high

−10.78%

Volume

2.48M

Market cap

$13.08B

ValuationView details →

P/E (Fwd)

11.9x

EV/EBITDA

27.4x

P/E (TTM)

—

RSI (14)

63.3

MomentumView details →

1D Return

−1.81%

YTD Return

+33.80%

SummaryUpdated Jun 1, 2026

Baxter International Inc. (NYSE:BAX) is a global healthcare company founded in 1931 and headquartered in Deerfield, Illinois. The company has evolved from its origins as a medical device manufacturer into a diversified healthcare products and services provider serving hospitals, dialysis centers, and other healthcare facilities worldwide. Baxter underwent a significant strategic transformation in recent years, completing the sale of its Kidney Care business (Vantive) to Carlyle Group in early 2025, allowing the company to focus on its core medical products, healthcare systems, and pharmaceutical businesses across approximately 100 countries.

Ask drillr about BAXTER INTERNATIONAL INC →

ValuationView details →

P/E (Fwd)

11.9x

P/E (TTM)

—

EV/EBITDA

27.4x

EV/Sales

1.8x

P/S (TTM)

1.1x

P/B (TTM)

2.1x

ProfitabilityView details →

Gross Margin

30.08%

Net Margin

−9.27%

EBITDA Margin

6.54%

ROE (TTM)

−17.13%

ROA (TTM)

−5.37%

Asset Turnover

0.58x

GrowthView details →

Revenue YoY

+5.36%

EPS YoY

—

FCF YoY

+103.60%

Revenue CAGR 3Y

+3.79%

EPS CAGR 3Y

−37.80%

EBITDA YoY

−27.54%

MomentumView details →

1D Return

−1.81%

YTD Return

+33.80%

1Y Return

+10.74%

RSI (14)

63.3

vs 50D SMA

+2.23%

vs 200D SMA

+21.14%

Capital & dividendView details →

Debt/Equity

1.56x

Current Ratio

1.95x

Quick Ratio

1.32x

Div Yield

0.16%

Div Rate

$0.04

Div Growth 1Y

−50.00%

EarningsView details →

EPS (Actual)

$0.56

EPS Surprise

52.80%

Beats (12Q)

9/12

Next Q EPS Est

$0.61

Avg Surprise (4Q)

16.74%

Rev Surprise

5.88%

Financials snapshotView financials →

Revenue (TTM)

11.47B

Net Income (TTM)

−1.06B

Op. CF (TTM)

1.32B

Next earningsOct 29, 2026 →

Latest newsMore news →

Barbara Oil Co. disclosed a new minority stake in Baxter International Inc., purchasing 40,000 shares worth about $853,000 in the second quarter.54d ago

Rocket Lab Corp appointed Agostino Ricupati as Vice President, Corporate Controller and Chief Accounting Officer, effective June 3, 2026.134d ago

Similar companies

Angelalign Technology Inc.06699.HK 南微医学688029.SH Shandong Weigao Group Medical Polymer Company Limited01066.HK Repligen CorporationRGEN The Cooper Companies, Inc.COO Avantor, Inc.AVTR Find similar companies →

Latest newsMore news →

Barbara Oil Co. disclosed a new minority stake in Baxter International Inc., purchasing 40,000 shares worth about $853,000 in the second quarter.54d ago Rocket Lab Corp appointed Agostino Ricupati as Vice President, Corporate Controller and Chief Accounting Officer, effective June 3, 2026.134d ago